Suzanne Messere | IR |
Stephen Willard | CEO |
Seth Van Voorhees | CFO |
Jonathan Javitt | Chief Scientist |
Jason Kolbert | Dawson James |
Vernon Bernadino | H.C. Wainwright |
Ed Woo | Ascendiant Capital |
Good afternoon and welcome to the NRx Pharmaceuticals Full Year 2022 Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Suzanne Messere, Stern Investor Relations.